Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling.
Publication
, Journal Article
Fiuzat, M; Burnett, JC
Published in: JACC Heart Fail
January 2015
Duke Scholars
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
January 2015
Volume
3
Issue
1
Start / End Page
68 / 69
Location
United States
Related Subject Headings
- Ventricular Remodeling
- Ventricular Dysfunction, Left
- Up-Regulation
- Spironolactone
- Receptors, Interleukin-1
- Myocardial Infarction
- Male
- Interleukins
- Heart Failure
- Galectin 3
Citation
APA
Chicago
ICMJE
MLA
NLM
Fiuzat, M., & Burnett, J. C. (2015). Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling. JACC Heart Fail, 3(1), 68–69. https://doi.org/10.1016/j.jchf.2014.10.003
Fiuzat, Mona, and John C. Burnett. “Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling.” JACC Heart Fail 3, no. 1 (January 2015): 68–69. https://doi.org/10.1016/j.jchf.2014.10.003.
Fiuzat M, Burnett JC. Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling. JACC Heart Fail. 2015 Jan;3(1):68–9.
Fiuzat, Mona, and John C. Burnett. “Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling.” JACC Heart Fail, vol. 3, no. 1, Jan. 2015, pp. 68–69. Pubmed, doi:10.1016/j.jchf.2014.10.003.
Fiuzat M, Burnett JC. Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling. JACC Heart Fail. 2015 Jan;3(1):68–69.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
January 2015
Volume
3
Issue
1
Start / End Page
68 / 69
Location
United States
Related Subject Headings
- Ventricular Remodeling
- Ventricular Dysfunction, Left
- Up-Regulation
- Spironolactone
- Receptors, Interleukin-1
- Myocardial Infarction
- Male
- Interleukins
- Heart Failure
- Galectin 3